The Oncology Drug Discovery Service is dedicated to oncology research, providing high-quality, timely and cost-effective oncology drug discovery and accelerating the development of the immunooncology product portfolio to develop new drugs that benefit human health.

The global Oncology Drug Discovery Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oncology Drug Discovery Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Drug Discovery Services.

Report Scope

The Oncology Drug Discovery Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncology Drug Discovery Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology Drug Discovery Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oncology Drug Discovery Services Market Report

Report Metric	Details
Report Name	Oncology Drug Discovery Services Market
CAGR	5%
Segment by Type	Identification Service Authentication Service Hit-to-lead and Lead Optimization Services Others
Segment by Application	Research Institutes Pharmaceutical Companies Biotechnology Companies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Charles River, Evotec, GE Healthcare Life Sciences, GenScript, Horizon Discovery, TCG Lifesciences, Zumutor, ChemPartner, Aquila BioMedical, Onconova, Vichem Chemie, GVK Biosciences, NuChem Therapeutics, Syncom, Envigo, DiverChim, Aurora, HD Biosciences, WuXi AppTec
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Drug Discovery Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oncology Drug Discovery Services Market report?

Ans: The main players in the Oncology Drug Discovery Services Market are Charles River, Evotec, GE Healthcare Life Sciences, GenScript, Horizon Discovery, TCG Lifesciences, Zumutor, ChemPartner, Aquila BioMedical, Onconova, Vichem Chemie, GVK Biosciences, NuChem Therapeutics, Syncom, Envigo, DiverChim, Aurora, HD Biosciences, WuXi AppTec

What are the Application segmentation covered in the Oncology Drug Discovery Services Market report?

Ans: The Applications covered in the Oncology Drug Discovery Services Market report are Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Others

What are the Type segmentation covered in the Oncology Drug Discovery Services Market report?

Ans: The Types covered in the Oncology Drug Discovery Services Market report are Identification Service, Authentication Service, Hit-to-lead and Lead Optimization Services, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncology Drug Discovery Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Identification Service

1.2.3 Authentication Service

1.2.4 Hit-to-lead and Lead Optimization Services

1.2.5 Others

1.3 Market by Application

1.3.1 Global Oncology Drug Discovery Services Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Research Institutes

1.3.3 Pharmaceutical Companies

1.3.4 Biotechnology Companies

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncology Drug Discovery Services Market Perspective (2019-2030)

2.2 Oncology Drug Discovery Services Growth Trends by Region

2.2.1 Global Oncology Drug Discovery Services Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Oncology Drug Discovery Services Historic Market Size by Region (2019-2024)

2.2.3 Oncology Drug Discovery Services Forecasted Market Size by Region (2025-2030)

2.3 Oncology Drug Discovery Services Market Dynamics

2.3.1 Oncology Drug Discovery Services Industry Trends

2.3.2 Oncology Drug Discovery Services Market Drivers

2.3.3 Oncology Drug Discovery Services Market Challenges

2.3.4 Oncology Drug Discovery Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncology Drug Discovery Services Players by Revenue

3.1.1 Global Top Oncology Drug Discovery Services Players by Revenue (2019-2024)

3.1.2 Global Oncology Drug Discovery Services Revenue Market Share by Players (2019-2024)

3.2 Global Oncology Drug Discovery Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Oncology Drug Discovery Services Revenue

3.4 Global Oncology Drug Discovery Services Market Concentration Ratio

3.4.1 Global Oncology Drug Discovery Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncology Drug Discovery Services Revenue in 2023

3.5 Oncology Drug Discovery Services Key Players Head office and Area Served

3.6 Key Players Oncology Drug Discovery Services Product Solution and Service

3.7 Date of Enter into Oncology Drug Discovery Services Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Drug Discovery Services Breakdown Data by Type

4.1 Global Oncology Drug Discovery Services Historic Market Size by Type (2019-2024)

4.2 Global Oncology Drug Discovery Services Forecasted Market Size by Type (2025-2030)

5 Oncology Drug Discovery Services Breakdown Data by Application

5.1 Global Oncology Drug Discovery Services Historic Market Size by Application (2019-2024)

5.2 Global Oncology Drug Discovery Services Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Oncology Drug Discovery Services Market Size (2019-2030)

6.2 North America Oncology Drug Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Oncology Drug Discovery Services Market Size by Country (2019-2024)

6.4 North America Oncology Drug Discovery Services Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oncology Drug Discovery Services Market Size (2019-2030)

7.2 Europe Oncology Drug Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Oncology Drug Discovery Services Market Size by Country (2019-2024)

7.4 Europe Oncology Drug Discovery Services Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oncology Drug Discovery Services Market Size (2019-2030)

8.2 Asia-Pacific Oncology Drug Discovery Services Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2019-2024)

8.4 Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oncology Drug Discovery Services Market Size (2019-2030)

9.2 Latin America Oncology Drug Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Oncology Drug Discovery Services Market Size by Country (2019-2024)

9.4 Latin America Oncology Drug Discovery Services Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncology Drug Discovery Services Market Size (2019-2030)

10.2 Middle East & Africa Oncology Drug Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2019-2024)

10.4 Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Charles River

11.1.1 Charles River Company Detail

11.1.2 Charles River Business Overview

11.1.3 Charles River Oncology Drug Discovery Services Introduction

11.1.4 Charles River Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.1.5 Charles River Recent Development

11.2 Evotec

11.2.1 Evotec Company Detail

11.2.2 Evotec Business Overview

11.2.3 Evotec Oncology Drug Discovery Services Introduction

11.2.4 Evotec Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.2.5 Evotec Recent Development

11.3 GE Healthcare Life Sciences

11.3.1 GE Healthcare Life Sciences Company Detail

11.3.2 GE Healthcare Life Sciences Business Overview

11.3.3 GE Healthcare Life Sciences Oncology Drug Discovery Services Introduction

11.3.4 GE Healthcare Life Sciences Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.3.5 GE Healthcare Life Sciences Recent Development

11.4 GenScript

11.4.1 GenScript Company Detail

11.4.2 GenScript Business Overview

11.4.3 GenScript Oncology Drug Discovery Services Introduction

11.4.4 GenScript Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.4.5 GenScript Recent Development

11.5 Horizon Discovery

11.5.1 Horizon Discovery Company Detail

11.5.2 Horizon Discovery Business Overview

11.5.3 Horizon Discovery Oncology Drug Discovery Services Introduction

11.5.4 Horizon Discovery Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.5.5 Horizon Discovery Recent Development

11.6 TCG Lifesciences

11.6.1 TCG Lifesciences Company Detail

11.6.2 TCG Lifesciences Business Overview

11.6.3 TCG Lifesciences Oncology Drug Discovery Services Introduction

11.6.4 TCG Lifesciences Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.6.5 TCG Lifesciences Recent Development

11.7 Zumutor

11.7.1 Zumutor Company Detail

11.7.2 Zumutor Business Overview

11.7.3 Zumutor Oncology Drug Discovery Services Introduction

11.7.4 Zumutor Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.7.5 Zumutor Recent Development

11.8 ChemPartner

11.8.1 ChemPartner Company Detail

11.8.2 ChemPartner Business Overview

11.8.3 ChemPartner Oncology Drug Discovery Services Introduction

11.8.4 ChemPartner Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.8.5 ChemPartner Recent Development

11.9 Aquila BioMedical

11.9.1 Aquila BioMedical Company Detail

11.9.2 Aquila BioMedical Business Overview

11.9.3 Aquila BioMedical Oncology Drug Discovery Services Introduction

11.9.4 Aquila BioMedical Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.9.5 Aquila BioMedical Recent Development

11.10 Onconova

11.10.1 Onconova Company Detail

11.10.2 Onconova Business Overview

11.10.3 Onconova Oncology Drug Discovery Services Introduction

11.10.4 Onconova Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.10.5 Onconova Recent Development

11.11 Vichem Chemie

11.11.1 Vichem Chemie Company Detail

11.11.2 Vichem Chemie Business Overview

11.11.3 Vichem Chemie Oncology Drug Discovery Services Introduction

11.11.4 Vichem Chemie Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.11.5 Vichem Chemie Recent Development

11.12 GVK Biosciences

11.12.1 GVK Biosciences Company Detail

11.12.2 GVK Biosciences Business Overview

11.12.3 GVK Biosciences Oncology Drug Discovery Services Introduction

11.12.4 GVK Biosciences Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.12.5 GVK Biosciences Recent Development

11.13 NuChem Therapeutics

11.13.1 NuChem Therapeutics Company Detail

11.13.2 NuChem Therapeutics Business Overview

11.13.3 NuChem Therapeutics Oncology Drug Discovery Services Introduction

11.13.4 NuChem Therapeutics Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.13.5 NuChem Therapeutics Recent Development

11.14 Syncom

11.14.1 Syncom Company Detail

11.14.2 Syncom Business Overview

11.14.3 Syncom Oncology Drug Discovery Services Introduction

11.14.4 Syncom Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.14.5 Syncom Recent Development

11.15 Envigo

11.15.1 Envigo Company Detail

11.15.2 Envigo Business Overview

11.15.3 Envigo Oncology Drug Discovery Services Introduction

11.15.4 Envigo Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.15.5 Envigo Recent Development

11.16 DiverChim

11.16.1 DiverChim Company Detail

11.16.2 DiverChim Business Overview

11.16.3 DiverChim Oncology Drug Discovery Services Introduction

11.16.4 DiverChim Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.16.5 DiverChim Recent Development

11.17 Aurora

11.17.1 Aurora Company Detail

11.17.2 Aurora Business Overview

11.17.3 Aurora Oncology Drug Discovery Services Introduction

11.17.4 Aurora Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.17.5 Aurora Recent Development

11.18 HD Biosciences

11.18.1 HD Biosciences Company Detail

11.18.2 HD Biosciences Business Overview

11.18.3 HD Biosciences Oncology Drug Discovery Services Introduction

11.18.4 HD Biosciences Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.18.5 HD Biosciences Recent Development

11.19 WuXi AppTec

11.19.1 WuXi AppTec Company Detail

11.19.2 WuXi AppTec Business Overview

11.19.3 WuXi AppTec Oncology Drug Discovery Services Introduction

11.19.4 WuXi AppTec Revenue in Oncology Drug Discovery Services Business (2019-2024)

11.19.5 WuXi AppTec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Charles River

Evotec AG

GE Healthcare Life Sciences

List of Tables

Table 1. Global Oncology Drug Discovery Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Identification Service

Table 3. Key Players of Authentication Service

Table 4. Key Players of Hit-to-lead and Lead Optimization Services

Table 5. Key Players of Others

Table 6. Global Oncology Drug Discovery Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Oncology Drug Discovery Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Oncology Drug Discovery Services Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Oncology Drug Discovery Services Market Share by Region (2019-2024)

Table 10. Global Oncology Drug Discovery Services Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Oncology Drug Discovery Services Market Share by Region (2025-2030)

Table 12. Oncology Drug Discovery Services Market Trends

Table 13. Oncology Drug Discovery Services Market Drivers

Table 14. Oncology Drug Discovery Services Market Challenges

Table 15. Oncology Drug Discovery Services Market Restraints

Table 16. Global Oncology Drug Discovery Services Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Oncology Drug Discovery Services Market Share by Players (2019-2024)

Table 18. Global Top Oncology Drug Discovery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drug Discovery Services as of 2023)

Table 19. Ranking of Global Top Oncology Drug Discovery Services Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Oncology Drug Discovery Services Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Oncology Drug Discovery Services Product Solution and Service

Table 23. Date of Enter into Oncology Drug Discovery Services Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Oncology Drug Discovery Services Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Oncology Drug Discovery Services Revenue Market Share by Type (2019-2024)

Table 27. Global Oncology Drug Discovery Services Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Oncology Drug Discovery Services Revenue Market Share by Type (2025-2030)

Table 29. Global Oncology Drug Discovery Services Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Oncology Drug Discovery Services Revenue Market Share by Application (2019-2024)

Table 31. Global Oncology Drug Discovery Services Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Oncology Drug Discovery Services Revenue Market Share by Application (2025-2030)

Table 33. North America Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Oncology Drug Discovery Services Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Oncology Drug Discovery Services Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Oncology Drug Discovery Services Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Oncology Drug Discovery Services Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Oncology Drug Discovery Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Oncology Drug Discovery Services Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Oncology Drug Discovery Services Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2025-2030) & (US$ Million)

Table 48. Charles River Company Detail

Table 49. Charles River Business Overview

Table 50. Charles River Oncology Drug Discovery Services Product

Table 51. Charles River Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 52. Charles River Recent Development

Table 53. Evotec Company Detail

Table 54. Evotec Business Overview

Table 55. Evotec Oncology Drug Discovery Services Product

Table 56. Evotec Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 57. Evotec Recent Development

Table 58. GE Healthcare Life Sciences Company Detail

Table 59. GE Healthcare Life Sciences Business Overview

Table 60. GE Healthcare Life Sciences Oncology Drug Discovery Services Product

Table 61. GE Healthcare Life Sciences Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 62. GE Healthcare Life Sciences Recent Development

Table 63. GenScript Company Detail

Table 64. GenScript Business Overview

Table 65. GenScript Oncology Drug Discovery Services Product

Table 66. GenScript Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 67. GenScript Recent Development

Table 68. Horizon Discovery Company Detail

Table 69. Horizon Discovery Business Overview

Table 70. Horizon Discovery Oncology Drug Discovery Services Product

Table 71. Horizon Discovery Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 72. Horizon Discovery Recent Development

Table 73. TCG Lifesciences Company Detail

Table 74. TCG Lifesciences Business Overview

Table 75. TCG Lifesciences Oncology Drug Discovery Services Product

Table 76. TCG Lifesciences Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 77. TCG Lifesciences Recent Development

Table 78. Zumutor Company Detail

Table 79. Zumutor Business Overview

Table 80. Zumutor Oncology Drug Discovery Services Product

Table 81. Zumutor Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 82. Zumutor Recent Development

Table 83. ChemPartner Company Detail

Table 84. ChemPartner Business Overview

Table 85. ChemPartner Oncology Drug Discovery Services Product

Table 86. ChemPartner Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 87. ChemPartner Recent Development

Table 88. Aquila BioMedical Company Detail

Table 89. Aquila BioMedical Business Overview

Table 90. Aquila BioMedical Oncology Drug Discovery Services Product

Table 91. Aquila BioMedical Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 92. Aquila BioMedical Recent Development

Table 93. Onconova Company Detail

Table 94. Onconova Business Overview

Table 95. Onconova Oncology Drug Discovery Services Product

Table 96. Onconova Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 97. Onconova Recent Development

Table 98. Vichem Chemie Company Detail

Table 99. Vichem Chemie Business Overview

Table 100. Vichem Chemie Oncology Drug Discovery Services Product

Table 101. Vichem Chemie Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 102. Vichem Chemie Recent Development

Table 103. GVK Biosciences Company Detail

Table 104. GVK Biosciences Business Overview

Table 105. GVK Biosciences Oncology Drug Discovery Services Product

Table 106. GVK Biosciences Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 107. GVK Biosciences Recent Development

Table 108. NuChem Therapeutics Company Detail

Table 109. NuChem Therapeutics Business Overview

Table 110. NuChem Therapeutics Oncology Drug Discovery Services Product

Table 111. NuChem Therapeutics Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 112. NuChem Therapeutics Recent Development

Table 113. Syncom Company Detail

Table 114. Syncom Business Overview

Table 115. Syncom Oncology Drug Discovery Services Product

Table 116. Syncom Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 117. Syncom Recent Development

Table 118. Envigo Company Detail

Table 119. Envigo Business Overview

Table 120. Envigo Oncology Drug Discovery Services Product

Table 121. Envigo Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 122. Envigo Recent Development

Table 123. DiverChim Company Detail

Table 124. DiverChim Business Overview

Table 125. DiverChim Oncology Drug Discovery Services Product

Table 126. DiverChim Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 127. DiverChim Recent Development

Table 128. Aurora Company Detail

Table 129. Aurora Business Overview

Table 130. Aurora Oncology Drug Discovery Services Product

Table 131. Aurora Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 132. Aurora Recent Development

Table 133. HD Biosciences Company Detail

Table 134. HD Biosciences Business Overview

Table 135. HD Biosciences Oncology Drug Discovery Services Product

Table 136. HD Biosciences Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 137. HD Biosciences Recent Development

Table 138. WuXi AppTec Company Detail

Table 139. WuXi AppTec Business Overview

Table 140. WuXi AppTec Oncology Drug Discovery Services Product

Table 141. WuXi AppTec Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)

Table 142. WuXi AppTec Recent Development

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Oncology Drug Discovery Services Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Oncology Drug Discovery Services Market Share by Type: 2023 VS 2030

Figure 3. Identification Service Features

Figure 4. Authentication Service Features

Figure 5. Hit-to-lead and Lead Optimization Services Features

Figure 6. Others Features

Figure 7. Global Oncology Drug Discovery Services Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Oncology Drug Discovery Services Market Share by Application: 2023 VS 2030

Figure 9. Research Institutes Case Studies

Figure 10. Pharmaceutical Companies Case Studies

Figure 11. Biotechnology Companies Case Studies

Figure 12. Others Case Studies

Figure 13. Oncology Drug Discovery Services Report Years Considered

Figure 14. Global Oncology Drug Discovery Services Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Oncology Drug Discovery Services Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Oncology Drug Discovery Services Market Share by Region: 2023 VS 2030

Figure 17. Global Oncology Drug Discovery Services Market Share by Players in 2023

Figure 18. Global Top Oncology Drug Discovery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drug Discovery Services as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Oncology Drug Discovery Services Revenue in 2023

Figure 20. North America Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Oncology Drug Discovery Services Market Share by Country (2019-2030)

Figure 22. United States Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Oncology Drug Discovery Services Market Share by Country (2019-2030)

Figure 26. Germany Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Oncology Drug Discovery Services Market Share by Region (2019-2030)

Figure 34. China Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Oncology Drug Discovery Services Market Share by Country (2019-2030)

Figure 42. Mexico Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Oncology Drug Discovery Services Market Share by Country (2019-2030)

Figure 46. Turkey Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Charles River Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 49. Evotec Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 50. GE Healthcare Life Sciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 51. GenScript Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 52. Horizon Discovery Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 53. TCG Lifesciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 54. Zumutor Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 55. ChemPartner Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 56. Aquila BioMedical Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 57. Onconova Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 58. Vichem Chemie Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 59. GVK Biosciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 60. NuChem Therapeutics Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 61. Syncom Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 62. Envigo Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 63. DiverChim Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 64. Aurora Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 65. HD Biosciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 66. WuXi AppTec Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions